Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Combination of Entinostat and Enzalutamide in Advanced Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03829930
Recruitment Status : Recruiting
First Posted : February 4, 2019
Last Update Posted : August 8, 2019
Sponsor:
Information provided by (Responsible Party):
Jianqing Lin, George Washington University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : November 1, 2022
Estimated Study Completion Date : November 1, 2024
Publications:
Gore SD, Jiemjit A, Silverman LB, et al. Combined methyltransferase/histone deacetylase inhibition with 5-azacitidine and MS-275 in patients with MDS, CMMoL and AML: Clinical response, histone acetylation and DNA damage. Blood 2006; 108: Abstract 517